» Articles » PMID: 15142997

A Prospective, Randomized Study: Day 3 Versus Hatching Blastocyst Stage

Overview
Journal Hum Reprod
Date 2004 May 15
PMID 15142997
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recently, advances in human IVF-embryo transfer (ET) have been reported using sequential media and blastocyst stage ET. In our previous report, using a prospective, randomized study, no advantage was found using the blastocyst stage ET compared with day 3 ET. This study was performed in order to evaluate implantation and pregnancy rates of hatching blastocyst stage ET compared with conventional day 3 ET.

Methods And Results: A total of 480 patient cycles were evaluated using a prospective, randomized study. The pregnancy rate and implantation rate were compared between the day 3 ET (n = 240) and hatching blastocyst stage ET (Hat ET; n = 240). The Hat ET group had a pregnancy rate of 29.3% (55 out of 188) and an implantation rate of 21.4% (67 out of 313). The day 3 ET group had a pregnancy rate of 29.2% (70 out of 240) and an implantation rate of 19.1% (93 out of 488). In the Hat ET group, the pregnancy rate, implantation rate and ongoing pregnancy rate of day 5 ET and day 6 ET were all higher than the respective rates in the day 7-9 ET group.

Conclusion: We found that the pregnancy rate and implantation rate of ET with hatching stage blastocysts had no advantage compared with the conventional day 3 ET.

Citing Articles

Improving reproductive outcomes in frozen embryo transfer over fresh embryo transfer in women with endometrioma: A historical cohort study.

Pirooznia P, Mashayekhi M, Ghaffari F, Jahangiri N, Zolfaghari Z, Ahmadi F Int J Reprod Biomed. 2025; 22(11):857-870.

PMID: 39866586 PMC: 11757671. DOI: 10.18502/ijrm.v22i11.17819.


Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology.

Glujovsky D, Quinteiro Retamar A, Alvarez Sedo C, Ciapponi A, Cornelisse S, Blake D Cochrane Database Syst Rev. 2022; 5:CD002118.

PMID: 35588094 PMC: 9119424. DOI: 10.1002/14651858.CD002118.pub6.


Creation, effects on embryo quality, and clinical outcomes of a new embryo culture medium with 31 optimized components derived from human oviduct fluid: A prospective multicenter randomized trial.

Utsunomiya T, Yao T, Itoh H, Kai Y, Kumasako Y, Setoguchi M Reprod Med Biol. 2022; 21(1):e12459.

PMID: 35431648 PMC: 8999156. DOI: 10.1002/rmb2.12459.


Establishment of day 7 blastocyst freezing criteria using blastocyst diameter for single vitrified-warmed blastocyst transfer from live birth outcomes: a single-center, large cohort, retrospectively matched study.

Ueno S, Uchiyama K, Kuroda T, Okimura T, Yabuuchi A, Kobayashi T J Assist Reprod Genet. 2020; 37(9):2327-2335.

PMID: 32691193 PMC: 7492317. DOI: 10.1007/s10815-020-01882-8.


Cumulus-corona gene expression analysis combined with morphological embryo scoring in single embryo transfer cycles increases live birth after fresh transfer and decreases time to pregnancy.

Adriaenssens T, Van Vaerenbergh I, Coucke W, Segers I, Verheyen G, Anckaert E J Assist Reprod Genet. 2019; 36(3):433-443.

PMID: 30627993 PMC: 6439096. DOI: 10.1007/s10815-018-01398-2.